James Investment Research Inc Viatris Inc Transaction History

James Investment Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$12.09 - $14.68 $4,823 - $5,857	-399 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$13.25 - $15.13 $1,020 - $1,165	-77 Reduced 16.18%	399 $5,000
Q2 2021 Jul 26, 2021	SELL	$12.97 - $16.15 $1,815 - $2,261	-140 Reduced 22.73%	476 $7,000
Q1 2021 Apr 22, 2021	SELL	$13.59 - $18.54 $81,444 - $111,110	-5,993 Reduced 90.68%	616 $8,000
Q4 2020 Jan 27, 2021	BUY	$14.3 - $18.74 $94,508 - $123,852	6,609 New	6,609 $124,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.